Skip to content
SupplementMagazine

Everyday Benefits

Milk Thistle for Skin: 12 Studies Used a Cream, 3 Used a Pill

By Emrah Sümer, Founder & Managing Editor
October 31, 2026
A glass jar of white cream topped with a milk thistle flower head, beside a white dish of seeds on a marble windowsill
A glass jar of white cream topped with a milk thistle flower head, beside a white dish of seeds on a marble windowsill

Key takeaways

  • We found 15 human studies of milk thistle on a skin outcome: 12 applied it to the skin, 3 gave it by mouth.
  • The topical studies cover melasma, acne, rosacea, eczema, and radiation- and chemotherapy-related skin damage. Four were placebo-controlled; most were small and short.
  • The only oral acne trial found silymarin no better than doxycycline on one score and worse on the other. It had no placebo group.
  • No study tested milk thistle tea on skin, and none tested oral milk thistle for ageing or glow in healthy people.
  • Only 5 of 473 US milk thistle labels in the NIH database claim a skin benefit. The EU review lists allergic skin reactions among its side effects.

“Milk thistle benefits for skin” pages make a chain of claims that runs through the liver. Milk thistle protects the liver, the liver clears toxins, and clearer skin follows. Some add that the cast of the 2023 Barbie film drank milk thistle tea for their complexions.

We left the chain aside and looked for studies that measured skin. We searched PubMed for human studies of milk thistle or its extract, silymarin, with a skin outcome, read every abstract, and checked the NIH’s database of US supplement labels. Everything below was checked on 31 October 2026.

The result splits cleanly. Twelve of the fifteen human skin studies we found put milk thistle on the skin. Three put it in the mouth. None tested the tea.

Where the skin evidence actually is

Here are the topical studies, the ones in which silymarin was applied as a cream, gel or serum:

ConditionStudyPeopleCompared withResult
MelasmaAltaei 2012, Iraq96PlaceboImprovement reported from week 1
MelasmaWattanakrai 2022, Thailand232% hydroquinone, split-faceHydroquinone better on severity score; lightness similar
MelasmaIbrahim 2021, Egypt50Low-fluence laserNo significant difference between groups
AcneAtallah 2024, Egypt3030% salicylic acid peels, split-faceNo significant difference between sides
AcneDraelos 2024, Brazil and US/Germany56 + 40No control group described45% fewer inflammatory lesions at 12 weeks
AcneKim 2023, Korea22None, open-labelLesion counts fell over 4 weeks
Acne marksHu 2024, US25Laser aloneBetter with laser plus antioxidant serum
RosaceaBerardesca 2008, Italy46PlaceboRedness, papules and itching improved (silymarin combined with MSM)
EczemaIraji 2022, Iran40Mometasone steroid creamNo significant difference (cream also contained fumitory)
Radiation skin damageKarbasforooshan 2019, Iran40PlaceboLower dermatitis scores from week 3
Radiation skin damageBecker-Schiebe 2011, Germany101Standard care, not randomisedGrade 3 reactions 2% vs 28%
Chemotherapy hand-foot syndromeElyasi 2017, Iran40PlaceboLower scores at week 9

Four of these were placebo-controlled, and all four favoured silymarin. Most of the rest compared it with an established treatment and found no significant difference. That is encouraging, but it is not the same as proof, because small trials are often too small to detect a real difference.

The weaknesses are the usual ones. Most studies had 20 to 50 people. Most ran for one to three months. Three used combination products, so the effect cannot be pinned on silymarin alone. And one result is unusually clean: the largest placebo-controlled melasma study reports that “All patients were fully satisfied 100%” and that “No side effects were observed”. A result that perfect, with no side effects, is unusual in dermatology.

The most clinically interesting results are in cancer care. Two placebo-controlled Iranian trials used a 1% silymarin gel to protect skin during breast radiotherapy and during capecitabine chemotherapy. In both, skin damage developed in both groups but was later and milder with silymarin. Each trial had 40 patients. Anyone in that situation should raise it with their oncology team rather than buy a cream. These were pharmacy-prepared gels at a stated strength, and cancer skin care has its own protocols.

The three trials that used a pill

Taking milk thistle by mouth for skin has three trials behind it.

Acne, 2019, Iran. 60 patients took silymarin, the antibiotic doxycycline, or both. There was no placebo group. On one acne score, silymarin was not significantly different from doxycycline (p = 0.260). On the other, it did worse (p = 0.021). Adding silymarin to doxycycline did not significantly improve on doxycycline alone. The authors concluded that silymarin “is not as effective as doxycycline” but “can be a therapeutic option”.

Vitiligo, 2020, Iran. 34 patients had narrowband UVB light therapy plus either oral silymarin or a placebo. Both groups improved, and the silymarin group improved more. This is the only placebo-controlled trial we found of oral milk thistle on any skin outcome. It was in vitiligo, as an add-on to light therapy.

Vitiligo, 2024, Iran. 20 patients with vitiligo that had not responded to other treatment had hair-follicle transplants, with or without oral silymarin, for three months. The silymarin group repigmented more. There was no placebo.

That is the whole oral evidence for skin we could find. There is no trial of oral milk thistle for wrinkles, ageing, glow, clarity or general skin health in people without a skin disease.

What about the tea?

The tea idea took off in 2023. A London skin specialist told Vogue that milk thistle tea was part of the routine she set for the Barbie cast. Healthline reported the story, and one of the dermatologists it quoted said: “There isn’t definitive research”.

We found no study at all of milk thistle tea and skin. The European Medicines Agency does recognise milk thistle tea, but only as a traditional remedy “for the symptomatic relief of digestive disorders, sensation of fullness and indigestion and to support the liver function”. That is the whole of its approved use. Skin is not mentioned.

The labels mostly don’t make the claim

You might expect bottles to carry the claim. Mostly they don’t. Of the 473 on-market US milk thistle and silymarin label records in the NIH Dietary Supplement Label Database, 5 mention skin. Two are versions of the same Herbadiet product. The phrases are “May promote healthy skin”, “Supports skin health”, “Promotes skin health” and “Skin health”. The other 468 sell milk thistle for the liver, which is where its own evidence lies. Our milk thistle stacks page covers how thin even that is for combinations.

So “milk thistle for skin” is mostly a claim made by articles, influencers and skin-care brands. Supplement makers rarely print it on the bottle.

The skin effect the EU did record

The European Medicines Agency’s 2018 assessment of milk thistle fruit does contain one skin finding for oral use. It is a side effect. Reported adverse events include “allergic reactions (dermatitis, urticaria, skin rash, pruritus, anaphylaxis, asthma)”. The report says that overall, adverse events in trials were infrequent. Its only contraindication is allergy to milk thistle or to “plants of the Asteraceae (Compositae) family”, which includes ragweed, chrysanthemums, marigolds and daisies.

If you react to those plants, milk thistle in any form is more likely to give you a rash than clear one.

Where oral milk thistle meets skin treatment

One more trial is worth knowing about, though it measured blood tests rather than skin. Isotretinoin is a strong acne drug that can raise liver enzymes. In a 2020 Iranian trial, 74 acne patients taking it were given either 140 mg of silymarin a day or a starch placebo for 30 days. Liver enzymes AST and ALT stayed lower with silymarin. It is a single short trial, and it changes nothing about the acne itself. Anyone on isotretinoin should discuss supplements with the prescribing dermatologist, who will be monitoring those enzymes anyway.

What this means if you want to try it

  • For melasma, acne or rosacea, the studies used creams at stated strengths, mostly 1.4% silymarin for melasma and acne, for one to three months. They compared it with standard treatments and generally found it no worse. A product that lists silymarin among its ingredients without a percentage tells you nothing about how it compares.
  • For cancer-related skin damage, the two placebo-controlled trials are promising and small. Ask your oncology team.
  • For general skin health, ageing or glow, there is no oral evidence. That means capsules, extracts and tea. If you want an evidence-backed product for skin ageing, our collagen for skin page covers a supplement that has actually been tested on skin, and what those trials found.
  • If you have a daisy-family allergy, skip it.

We have no product box on this page. The evidence that exists is for creams at specific strengths, and the oral supplements most people mean when they search this phrase have nothing behind them for skin.

Frequently asked questions

Is milk thistle good for your skin?

Applied to the skin, it has some evidence. Small trials of silymarin creams and gels reported improvement in melasma, mild acne and rosacea, and less severe skin damage during breast radiotherapy and capecitabine chemotherapy. Taken by mouth, there is very little: three small trials, two of them in vitiligo alongside another treatment, and none in healthy skin. We found no trial of milk thistle tea for skin.

Does milk thistle help with acne?

As a cream, a 2024 Egyptian split-face study found 1.4% silymarin cream comparable to 30% salicylic acid peels in 30 people with mild to moderate acne. As a pill, the only trial we found, from Iran in 2019, gave 60 patients silymarin, doxycycline or both. Silymarin was not significantly different from doxycycline on one acne score (p = 0.260) but did worse on the other (p = 0.021), and there was no placebo group.

Does milk thistle tea give you glowing skin?

No study has tested it. The idea spread in 2023 after a skin specialist told Vogue that the Barbie film cast drank milk thistle tea during filming, as Healthline reported. We searched PubMed and found no trial of milk thistle tea, or of any oral milk thistle product, for skin appearance in healthy people.

Can milk thistle cream lighten melasma?

Several small trials suggest it helps, though less clearly than hydroquinone. In a 2022 Thai double-blind split-face trial of 23 patients, 2% hydroquinone reduced the melasma severity score by about 18% (significant) and 1.4% silymarin by about 7% (not significant), though skin lightness improved similarly and silymarin caused fewer side effects. A 2021 Egyptian trial found silymarin cream similar to a low-fluence laser in 50 women.

Can milk thistle cause skin problems?

Occasionally. The European Medicines Agency's 2018 assessment of milk thistle fruit lists allergic reactions, including dermatitis, hives, skin rash and itching, among reported adverse events, and says people allergic to the daisy family (Asteraceae) should not take it. Its overall assessment was that adverse events were infrequent.

Does milk thistle help skin by detoxing the liver?

That link has not been shown. The EU allows milk thistle as a traditional remedy for indigestion and 'to support the liver function', with no skin indication. The one skin-adjacent oral trial we found is about the liver itself: in 74 acne patients taking isotretinoin, 140 mg of silymarin a day kept liver enzymes from rising compared with placebo over 30 days. It measured blood tests, not skin.

Sources

Every claim above is drawn from these primary sources. Last checked July 2026.

  1. 1.Altaei T. The treatment of melasma by silymarin cream. BMC Dermatol 2012;12:18. PMID 23031632. Rabbit UV study plus 96 adults with melasma randomised to three groups, applied twice daily for 4 weeks; authors report 'All patients were fully satisfied 100%' and 'No side effects were observed'. Checked 31 October 2026
  2. 2.Wattanakrai P, Nimmannitya K. A Randomized, Double-Blind, Split-Face Study of Topical Silymarin vs 2% Hydroquinone Cream in Melasmas. J Drugs Dermatol 2022;21(12):1304-1310. PMID 36468967. 25 enrolled, 23 completed; 1.4% silymarin vs 2% hydroquinone for 3 months; mMASI reduction 17.97% (P = 0.02) hydroquinone vs 7.11% (P = 0.32) silymarin; RL*I improvement 14.56% vs 12.82%, no difference between sides (P = 0.715); more adverse effects with hydroquinone. Checked 31 October 2026
  3. 3.Ibrahim SMA, Farag AS, Ali MS, El-Gendy WMAF. Efficacy and Safety of Topical Silymarin Versus Low Fluence 1064-nm Q Switched Nd:YAG Laser in the Treatment of Melasma. Lasers Surg Med 2021;53(10):1341-1347. PMID 34101206. 50 women, 25 per group, silymarin cream 1.4% for 3 months vs six laser sessions; no significant difference between groups in mMASI change. Checked 31 October 2026
  4. 4.Atallah DA, Badran AY, Makhlouf AG, Mekkawy MM. Topical Silymarin Cream as a Novel Therapy Versus Salicylic Acid Peels in Acne Vulgaris: A Split-Face Clinical Trial. J Cutan Med Surg 2024;28(1):22-28. PMID 37942562. 30 patients, quasi-experimental split-face; silymarin 1.4% cream twice daily vs salicylic acid 30% peels every 2 weeks for 3 months; insignificant difference between sides. Checked 31 October 2026
  5. 5.Berardesca E, Cameli N, Cavallotti C, et al. Combined effects of silymarin and methylsulfonylmethane in the management of rosacea. J Cosmet Dermatol 2008;7(1):8-14. PMID 18254805. 46 patients, double-blind, placebo-controlled, 1 month; silymarin combined with methylsulfonylmethane (MSM) in one topical product. Checked 31 October 2026
  6. 6.Karbasforooshan H, Hosseini S, Elyasi S, Fani Pakdel A, Karimi G. Topical silymarin administration for prevention of acute radiodermatitis in breast cancer patients: A randomized, double-blind, placebo-controlled clinical trial. Phytother Res 2019;33(2):379-386. PMID 30479044. 40 patients, silymarin 1% gel once daily for 5 weeks; median NCI-CTCAE and RTOG scores significantly lower with silymarin from week 3 to week 5 (p < 0.05). Checked 31 October 2026
  7. 7.Elyasi S, Shojaee FSR, Allahyari A, Karimi G. Topical Silymarin Administration for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Phytother Res 2017;31(9):1323-1329. PMID 28635153. Pilot, 40 patients, silymarin gel 1% twice daily for 9 weeks; WHO HFS scores significantly lower at week 9 (p < 0.05). Checked 31 October 2026
  8. 8.Becker-Schiebe M, Mengs U, Schaefer M, Bulitta M, Hoffmann W. Topical use of a silymarin-based preparation to prevent radiodermatitis. Strahlenther Onkol 2011;187(8):485-491. PMID 21786113. 101 patients, nonrandomised; Leviaderm 51 vs standard of care 50; grade 2 toxicity at week 5 9.8% vs 52%; grade 3 2% vs 28%; authors call it a 'nonrandomized, observational trial' needing confirmation. Checked 31 October 2026
  9. 9.Iraji F, Sharif Makhmalzadeh B, Abedini M, Aghaei A, Siahpoush A. Effect of herbal cream containing Fumaria officinalis and silymarin for treatment of eczema. Avicenna J Phytomed 2022;12(2):155-162. PMID 35614885. 40 patients, herbal cream vs mometasone 0.1% for 2 weeks; SCORAD fell in both groups with no significant difference between them. Checked 31 October 2026
  10. 10.Draelos ZD, Kerscher M, Lynch S, White S, Choudhary H. A Silymarin Antioxidant Serum Improves Facial Acne Alone and as Part of a Treatment Regimen. J Drugs Dermatol 2024;23(4):233-238. PMID 38564394. Two studies: 56 subjects in Brazil for 12 weeks (45% reduction in inflammatory lesions) and 40 subjects in the US/Germany already on prescription acne treatment; the abstract describes no control group. Checked 31 October 2026
  11. 11.Kim J, Lee YN, Lee J, et al. Efficacy and safety of silymarin containing antioxidant serum as an adjuvant treatment of mild-to-moderate acne vulgaris: A prospective, open-label pilot study. J Cosmet Dermatol 2023;22(2):561-568. PMID 36204969. 22 patients, 0.5% silymarin serum for 4 weeks alongside existing acne medication; open-label, no control. Checked 31 October 2026
  12. 12.Hu JK, Quinonez RL, Antasiuk V, Waibel J. Treatment of Acne Vulgaris-Associated Post-Inflammatory Dyschromia With Combination of Non-Ablative Laser Therapy and Topical Antioxidants. J Drugs Dermatol 2024;23(9):769-773. PMID 39231081. 25 subjects; laser followed by a silymarin, salicylic acid, L-ascorbic acid and ferulic acid serum vs laser alone; authors list small sample size as a limitation. Checked 31 October 2026
  13. 13.Shie Morteza M, Hayati Z, Namazi N, Abdollahimajd F. Efficacy and safety of oral silymarin in comparison with oral doxycycline and their combination therapy in the treatment of acne vulgaris. Dermatol Ther 2019;32(6):e13095. PMID 31579978. 60 patients, 20 per group; silymarin vs doxycycline: GAGS p = .260, ASI lower for silymarin p = .021; combination vs doxycycline not significant; no placebo arm. Checked 31 October 2026
  14. 14.Jowkar F, Godarzi H, Parvizi MM. Can we consider silymarin as a treatment option for vitiligo? A double-blind controlled randomized clinical trial of phototherapy plus oral Silybum marianum product versus phototherapy alone. J Dermatolog Treat 2020;31(3):256-260. PMID 30935260. 34 patients, NB-UVB plus oral silymarin vs NB-UVB plus placebo; VASI fell more with silymarin; authors recommend further studies. Checked 31 October 2026
  15. 15.Feily A, Hosseinpour M, Samipour L, et al. Silymarin in combination with hair follicle transplantation as a potential treatment for refractory vitiligo: A double-blind randomized controlled trial. J Cosmet Dermatol 2024;23(12):4167-4172. PMID 39161267. 20 patients, follicle transplantation plus oral silymarin vs transplantation alone, 3 months. Checked 31 October 2026
  16. 16.Mirnezami M, Jafarimanesh H, Rezagholizamenjany M, Alimoradian A, Ranjbaran M. The effect of silymarin on liver enzymes in patients taking isotretinoin: A randomized clinical trial. Dermatol Ther 2020;33(2):e13236. PMID 31997509. 74 acne patients on isotretinoin, 140 mg Livergol capsule daily vs starch placebo for 30 days; AST and ALT differed significantly at the end (p < .05). Liver outcome, not skin. Checked 31 October 2026
  17. 17.European Medicines Agency, Committee on Herbal Medicinal Products. Assessment report on Silybum marianum (L.) Gaertn., fructus. EMA/HMPC/294188/2013, 5 June 2018. Traditional use indication: 'symptomatic relief of digestive disorders, sensation of fullness and indigestion and to support the liver function'; preparations include comminuted herbal substance for herbal tea; adverse events include 'allergic reactions (dermatitis, urticaria, skin rash, pruritus, anaphylaxis, asthma)'; contraindication 'hypersensitivity to the active substance and to plants of the Asteraceae (Compositae) family'; skin protection against UV damage listed among effects 'in experimental models'. Checked 31 October 2026
  18. 18.NIH Office of Dietary Supplements, Dietary Supplement Label Database: 473 on-market label records with milk thistle or silymarin in the product name, returned by a search for 'milk thistle', read 31 October 2026. Labels whose text mentions skin: 268759 Teraputics Pure Life Milk Thistle ('May promote healthy skin'); 295338 aSquared Nutrition Milk Thistle Extract 1000 mg ('Supports skin health'); 293640 and 257939 Herbadiet Organic Milk Thistle ('Promotes skin health'); 231350 Khroma Herbal Products Organic Milk Thistle ('Skin health'). Checked 31 October 2026
  19. 19.Healthline, 'Margot Robbie and Barbie Cast Drank Milk Thistle Tea for Glowing Skin: Does It Work?', 1 August 2023: reports that skin specialist Jasmine Vico told Vogue the cast drank milk thistle tea; dermatologist quoted saying 'There isn't definitive research'. Checked 31 October 2026